Brain Edema

• EMA withdrawal · 2021-03-19
  EMA Application withdrawn: Dexamethasone Taw (Dexamethasone (sodium phosphate)) — Taw Pharma (Ireland) Ltd

  EMA withdrew the application for Dexamethasone Taw (dexamethasone sodium phosphate) by Taw Pharma (Ireland) Ltd.

• CLINICAL_TRIALS withdrawal · 2008-01-03
  Clinical Trial Update: XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema [Phase 3]

  Phase 3 trial of XERECEPT (human corticotropin-releasing factor) in primary glioma patients requiring dexamethasone to treat peritumoral bra…